Latest news with #OrgabioHoldingsBerhad
Yahoo
23-05-2025
- Business
- Yahoo
Orgabio Holdings Berhad Third Quarter 2025 Earnings: EPS: RM0.004 (vs RM0.009 in 3Q 2024)
Revenue: RM28.0m (up 25% from 3Q 2024). Net income: RM1.10m (down 48% from 3Q 2024). Profit margin: 3.9% (down from 9.5% in 3Q 2024). The decrease in margin was driven by higher expenses. EPS: RM0.004 (down from RM0.009 in 3Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Orgabio Holdings Berhad shares are down 6.5% from a week ago. It is worth noting though that we have found 2 warning signs for Orgabio Holdings Berhad (1 makes us a bit uncomfortable!) that you need to take into consideration. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
14-04-2025
- Business
- Yahoo
Some Investors May Be Worried About Orgabio Holdings Berhad's (KLSE:ORGABIO) Returns On Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. However, after briefly looking over the numbers, we don't think Orgabio Holdings Berhad (KLSE:ORGABIO) has the makings of a multi-bagger going forward, but let's have a look at why that may be. We've discovered 2 warning signs about Orgabio Holdings Berhad. View them for free. Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. To calculate this metric for Orgabio Holdings Berhad, this is the formula: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.10 = RM6.9m ÷ (RM89m - RM22m) (Based on the trailing twelve months to December 2024). Therefore, Orgabio Holdings Berhad has an ROCE of 10%. By itself that's a normal return on capital and it's in line with the industry's average returns of 9.7%. Check out our latest analysis for Orgabio Holdings Berhad While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you'd like to look at how Orgabio Holdings Berhad has performed in the past in other metrics, you can view this free graph of Orgabio Holdings Berhad's past earnings, revenue and cash flow. In terms of Orgabio Holdings Berhad's historical ROCE movements, the trend isn't fantastic. Around five years ago the returns on capital were 23%, but since then they've fallen to 10%. Although, given both revenue and the amount of assets employed in the business have increased, it could suggest the company is investing in growth, and the extra capital has led to a short-term reduction in ROCE. And if the increased capital generates additional returns, the business, and thus shareholders, will benefit in the long run. Even though returns on capital have fallen in the short term, we find it promising that revenue and capital employed have both increased for Orgabio Holdings Berhad. These trends don't appear to have influenced returns though, because the total return from the stock has been mostly flat over the last year. So we think it'd be worthwhile to look further into this stock given the trends look encouraging. One final note, you should learn about the 2 warning signs we've spotted with Orgabio Holdings Berhad (including 1 which shouldn't be ignored) . For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Associated Press
28-02-2025
- Business
- Associated Press
Orgabio Reports Strong Q2 FY2025 Results with 36.2% Revenue Growth to RM25.40 Million
KUALA LUMPUR, MALAYSIA / ACCESS Newswire Orgabio Holdings Berhad ('Orgabio' or the 'Company') a leading instant beverage premix manufacturer in Malaysia, announced a strong financial performance for the second quarter ended 31 December 2024 ('Q2 FY2025"), reflecting sustained business expansion and increasing market demand. The Company recorded revenue of RM25.40 million, a 36.2% year-on-year growth from RM18.66 million in Q2 FY2024, driven by higher demand for its manufacturing services from third-party brand owners. Domestically, revenue surged 75.2% to RM12.49 million, while international sales grew 11.99% to RM12.91 million, underscoring Orgabio's expanding global footprint. Profit Before Tax ('PBT') increased 7.3% to RM1.86 million, while Profit After Tax ('PAT') climbed 30.4% to RM1.27 million, supported by stronger sales volumes and operational efficiencies. On a cumulative basis, Orgabio reported total revenue of RM48.84 million for the first half of the financial year ('1H FY2025"), a significant 58.5% increase from RM30.81 million in the same period last year. PBT for 1H FY2025 increased to RM3.57 million, up 91.9% from RM1.86 million in 1H FY2024, while PAT surged 129.9% to RM2.34 million from RM1.02 million in 1H FY2024, reflecting strong growth momentum. Orgabio Holdings Berhad Yong Hien Voon, Chief Executive Officer and Executive Director of Orgabio Holdings Berhad commented: 'We are pleased with our strong Q2 FY2025 performance, which reflects the trust of our clients and our ability to scale effectively. The sustained demand for our instant beverage solutions, both domestically and internationally, continues to drive our growth. As we expand, we remain committed to supporting our clients' business plans by ensuring a reliable supply of high-quality products while maintaining vigilance over raw material cost fluctuations. Despite fluctuating production costs, we continue to optimise efficiency and profitability.' Mr. Ean Yong added: 'The global instant beverage market is poised for substantial growth, projected to expand from USD 61.64 billion in 2023 to USD 103.75 billion by 2031, at a CAGR of 6.94%. Malaysia's instant beverage premix market is also expected to grow from USD 521.65 million in 2022 to USD 835.85 million by 2029, with a CAGR of 6.97%, driven by increasing demand for convenience, longer shelf life, and consistent taste. With our newly completed factory capable of producing up to 230 million sachets annually, Orgabio is well-positioned to capitalise on these opportunities, diversify its product portfolio, and expand into new markets.' Orgabio remains committed to strengthening its presence in both domestic and international markets by fulfilling secured orders and actively pursuing new business opportunities. With enhanced production capacity and a focus on product innovation, the Company is set to drive sustainable growth and long-term value creation. ABOUT ORGABIO HOLDINGS BERHAD Orgabio Holdings Berhad ('Orgabio' or the 'Company') was founded in 2002 by Dato' Ean Yong Tin Sin as a private label ('OEM' or 'ODM') manufacturer specialising in coffee and food supplement premixes. Over the years, Orgabio has expanded into one of Malaysia's leading instant beverage premix OEM manufacturers, producing over 100 million sachets annually. With 85 employees, the Company remains committed to its 'customer first' principle, delivering high-quality, customised beverage solutions while continuously innovating to support its clients' growth in both domestic and international markets. Issued By: Swan Consultancy Sdn. Bhd. on behalf of Orgabio Holdings Berhad William Yeo
